Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Bridging the lesion—engineering a permissive substrate for nerve regeneration

Bridging the lesion—engineering a permissive substrate for nerve regeneration

Regenerative Biomaterials, 2015 · DOI: 10.1093/rb/rbv012 · Published: April 7, 2015

Spinal Cord InjuryRegenerative MedicineBiomedical

Simple Explanation

Biomaterial-based strategies aim to restore connectivity after spinal cord injury by bridging the lesion and providing a favorable environment for axon regrowth. Implantable scaffolds can offer mechanical support, physical guidance for axon regrowth, and deliver therapeutic molecules or cells to alleviate the hostile environment. To address the multifaceted inhibitory environment of a spinal cord injury, a multifaceted therapeutic approach is crucial.

Study Duration
Not specified
Participants
Not specified
Evidence Level
Review

Key Findings

  • 1
    Multiple inhibitory mechanisms hamper regeneration after spinal cord injury, establishing a hostile environment for neuronal cell growth.
  • 2
    Scaffold design is evolving from simple hollow conduits to complex architectures that can modulate cell fate.
  • 3
    Combining scaffolds, cells, drugs, and nucleic acids shows promise in preclinical studies for spinal cord injury treatment.

Research Summary

Biomaterial-based strategies focus on bridging the spinal cord lesion, providing a favorable substrate, and guiding axonal re-growth. Following SCI, inhibitory mechanisms create a hostile environment, which implantable scaffolds aim to alleviate through mechanical support and delivery of therapeutics. Progress in identifying molecules targeting inhibition after SCI, combined with scaffolds and/or cells, is described and discussed.

Practical Implications

Scaffold Design

Develop scaffolds with complex architectures to modulate cell fate and enhance regeneration.

Combination Therapies

Explore combined strategies involving scaffolds, cells, drugs, and nucleic acids for multifaceted therapeutic effects.

Targeted Delivery

Utilize scaffolds for in situ delivery of therapeutic molecules to alleviate the hostile environment after SCI.

Study Limitations

  • 1
    Inefficient clearance of myelin debris by microglia and macrophages in the CNS
  • 2
    Mechanical barrier for axonal re-growth
  • 3
    Difficulty identifying the appropriate scaffold design, the best cell source and the correct drug/molecule cocktail and dose

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury